REPLIGEN CORP — Director's Dealing 2018

Mar 12, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2018-03-08

Reporting Person: RYAN THOMAS F JR (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-08	Common Stock	M	1000	$3.22	Acquired	9700	Direct
2018-03-08	Common Stock	M	3696	$18.12	Acquired	13396	Direct
2018-03-08	Common Stock	S	4696	$36.1567	Disposed	8700	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-08	Stock Option (Right to Buy)	$3.22	M	1000	Disposed	2021-12-15	Common Stock (1000)	Direct
2018-03-08	Stock Option (Right to Buy)	$18.12	M	3696	Disposed	2024-05-15	Common Stock (3696)	Direct

Footnotes

F1: $36.1567 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.03 to $36.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2: This option is currently exercisable.